Zobrazeno 1 - 10
of 134
pro vyhledávání: '"M. Hövels"'
Increasing the information provided by probabilistic sensitivity analysis: The relative density plot
Autor:
Joost W. Geenen, Rick A. Vreman, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels, Renske M. T. Ten Ham
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Results of probabilistic sensitivity analyses (PSA) are frequently visualized as a scatterplot, which is limited through overdrawing and a lack of insight in relative density. To overcome these limitations, we have developed the R
Externí odkaz:
https://doaj.org/article/2553ae0e6ad6472c8c4eede77ea9540f
Autor:
Charlotte L. Bekker, Helga Gardarsdottir, Antoine C. G. Egberts, Hendrik A. Molenaar, Marcel L. Bouvy, Bart J. F. van den Bemt, Anke M. Hövels
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Redispensing unused medications that have been returned to outpatient pharmacies by patients may reduce waste and healthcare costs. However, little is known regarding the extra costs associated with this process, nor the price lev
Externí odkaz:
https://doaj.org/article/ae621839238445418872a2e65e7b2260
Autor:
Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels, Andre W. Broekmans, Hubert G.M. Leufkens, Olaf H. Klungel
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 11, Iss , Pp 121-130 (2018)
Advanced therapy medicinal products (ATMPs) hold promise as treatments for previously untreatable and high-burden diseases. Expectations are high and active company pipelines are observed, yet only 10 market authorizations were approved in Europe. Ou
Externí odkaz:
https://doaj.org/article/d1e10b2078114479a61d2de16d64634b
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Background: In many countries, Budget Impact (BI) informs reimbursement decisions. Evidence has shown that decision-makers have restricted access based on high BI estimates but studies show that BI estimates are often inaccurate. Objective: To assess
Externí odkaz:
https://doaj.org/article/31bee768a57a4f7b81d61f585da3c894
Autor:
J. M. van den Heuvel, A. M. Hövels, H. R. Büller, A. K. Mantel-Teeuwisse, A. de Boer, A. H. Maitland-van der Zee
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background In 2012, around 400.000 patients in the Netherlands were treated with Vitamin K Antagonists (VKA) for thromboembolic diseases. Since 2011, non-VKA oral anticoagulants (NOACs) are available. NOACs do not require frequent INR monito
Externí odkaz:
https://doaj.org/article/27958c4f5cb74c558309e1cd43ca9ab5
Autor:
Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert-Jan Creemers, Birgit A.L.M. Deiman, Jesse J. Swen, Saskia Houterman, Stijn L.W. Koolen, Sander Bins, Anna M.J. Thijs, Marjan M.J. Laven, Anke M. Hövels, Saskia A.C. Luelmo, Danny Houtsma, Katerina Shulman, Howard L. McLeod, Ron H.N. van Schaik, Henk-Jan Guchelaar, Ron H.J. Mathijssen, Hans Gelderblom, Maarten J. Deenen
Publikováno v:
European Journal of Cancer, 162, 148-157. Elsevier Ltd.
European Journal of Cancer, 162, 148-157. ELSEVIER SCI LTD
European Journal of Cancer, 162, 148-157. ELSEVIER SCI LTD
Aim: To determine the safety, feasibility, pharmacokinetics, and cost of UGT1A1 genotype-guided dosing of irinotecan.Patients and methods: In this prospective, multicentre, non-randomised study, patients intended for treatment with irinotecan were pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f960399e216012a1be5fc64b0f0983
https://doi.org/10.1016/j.ejca.2021.12.009
https://doi.org/10.1016/j.ejca.2021.12.009
Autor:
T I Armina Padmasawitri, Gerardus W Frederix, Bachti Alisjahbana, Olaf Klungel, Anke M Hövels
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0193293 (2018)
Structural approach disparities were minimally addressed in past systematic reviews of model-based cost-effectiveness analyses addressing Tuberculosis management strategies. This review aimed to identify the structural approach disparities in model-b
Externí odkaz:
https://doaj.org/article/30549641777648a58a904c412e4456d8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Renske M.T. ten Ham, Alwin D. R. Huitema, Rick A. Vreman, Andre M. Bergman, Hilde Rosing, Merel van Nuland, Anke M. Hövels, Laurens G. de Graaf, Jos H. Beijnen
Publikováno v:
Value in Health. 24:121-128
Objectives Abiraterone acetate is registered for the treatment of metastatic castration-sensitive and resistant prostate cancer (mCRPC). Treatment outcome is associated with plasma trough concentrations (Cmin) of abiraterone. Patients with a plasma C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8b6af34c83b1b893d65f35a013a8fb
https://doi.org/10.1016/j.jval.2020.04.1838
https://doi.org/10.1016/j.jval.2020.04.1838
Autor:
Ting Wang, Anke M. Hövels, Iga Lipska, Neil McAuslane, Lawrence Liberti, Hubert G. M. Leufkens
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:332-348
ObjectivesThe objectives of the study were to establish a benchmarking tool to collect metrics to enable increased clarity regarding the differences and similarities across health technology assessment (HTA) agencies, to assess performance within and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e690569011de33be84d18957ffb8a5
https://doi.org/10.1017/s0266462320000598
https://doi.org/10.1017/s0266462320000598